-
Posted: November 3rd, 2023, 2:00am GMT
Conditions: Pancreatic Acinar Cell Carcinoma; Pancreatic Adenocarcinoma; Pancreatic Adenosquamous Carcinoma; Pancreatic Carcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Squamous Cell Carcinoma; Stage IV Pancreatic Cancer AJCC v8
Interventions: Drug: Nab paclitaxel; Drug: Gemcitabine; Drug: Cisplatin; Procedure: Magnetic Resonance Imaging; Procedure: Computed Tomography; Procedure: Biospecimen Collection
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 14th, 2022, 3:00pm GMT
Conditions: Pancreatic Cancer; Pancreatic Disease; Microbial Colonization
Intervention: Other: No any intervention
Sponsor: Ruijin Hospital
Recruiting
-
Posted: August 2nd, 2021, 2:00pm GMT
Conditions: Melanoma; Solid Tumor; CRAF Gene Amplification; RAF1 Gene Amplification; BRAF Gene Fusion; BRAF Fusion; CRAF Gene Fusion; CRAF Fusion; RAF1 Gene Fusion; RAF1 Fusion; Thyroid Cancer, Papillary; Spitzoid Melanoma; Pilocytic Astrocytoma; Pilocytic Astrocytoma, Adult; Non Small Cell Lung Cancer; Non-Small Cell Adenocarcinoma; Colorectal Cancer; Pancreatic Acinar Carcinoma; Spitzoid Malignant Melanoma; Bladder Cancer; Bladder Urothelial Carcinoma; MAP Kinase Family Gene Mutation; RAS Mutation; RAF Mutation; MEK Mutation
Interventions: Drug: Tovorafenib; Drug: Pimasertib
Sponsor: Day One Biopharmaceuticals, Inc.
Recruiting
-
Posted: November 4th, 2019, 3:00pm GMT
Conditions: Pancreatic Adenocarcinoma Metastatic; BRCA1 Mutation; BRCA2 Mutation; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer; Metastatic Pancreatic Cancer; Metastatic Pancreatic Ductal Adenocarcinoma; Breast Cancer Metastatic; Breast Cancer Stage IV; Pancreatic Cancer Stage IV; HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma; Adenocarcinoma of the Breast; PALB2 Gene Mutation
Interventions: Drug: Melphalan; Drug: BCNU; Drug: Vitamin B12B; Drug: Vitamin C; Drug: Ethanol; Device: Autologous Hematopoietic Stem Cells
Sponsors: General Oncology, Inc.; Myriad Genetics, Inc.
Recruiting
-
Posted: January 18th, 2019, 3:00pm GMT
Conditions: Pancreatic Cancer; Pancreatic Disease
Intervention:
Sponsor: Ruijin Hospital
Recruiting
-
Posted: June 30th, 2014, 2:00am GMT
Conditions: Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Stage IV Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride; Drug: Selinexor; Other: Pharmacological Study; Other: Laboratory Biomarker Analysis; Drug: Nab paclitaxel
Sponsors: Mohammed Najeeb Al Hallak
Completed
-
Posted: January 28th, 2014, 3:00am GMT
Conditions: Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Stage I Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer
Interventions: Drug: oxaliplatin; Drug: leucovorin calcium; Drug: irinotecan hydrochloride; Drug: fluorouracil; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis
Sponsors: Yale University; National Cancer Institute (NCI)
Active, not recruiting
-
Posted: April 8th, 2009, 2:00am GMT
Conditions: Adult Solid Neoplasm; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Recurrent Pancreatic Carcinoma; Stage IV Pancreatic Cancer AJCC v6 and v7
Interventions: Other: Diagnostic Laboratory Biomarker Analysis; Drug: Erlotinib Hydrochloride; Drug: Gemcitabine Hydrochloride; Drug: Vismodegib
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: April 30th, 2008, 2:00am GMT
Conditions: Locally Advanced Pancreatic Adenocarcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IV Pancreatic Cancer AJCC v6 and v7
Interventions: Biological: Falimarev; Biological: Inalimarev; Other: Laboratory Biomarker Analysis; Biological: Sargramostim
Sponsors: National Cancer Institute (NCI)
Active, not recruiting